September 30, 2009 - The founding members of the American Society of Clinical Radiation Oncology (ASCRO) announced its addition as a new professional non-profit organization primarily dedicated to acquiring a "Provider Status" for clinical radiation oncology physicists.
"ASCRO believes that the quality of patient care will be significantly enhanced when clinical radiation oncology physicists are given Provider Status. Such a status will allow them to make professional decisions based solely on the best interest of cancer patients," said Nabil Adnani, Ph.D., ASCRO's president and founding member. "By joining ASCRO in large numbers, clinical radiation oncology physicists will ensure, and for the first time in history, their true place as medical professionals," Dr. Adnani went on to say.
"Finally, a long overdue society is born. Clinical Radiation Oncology Physicists now have an organization they can call their own," said Ivan Brezovich, Ph.D., ASCRO's chairman and founding member.
ASCRO will work with existing organizations and will seek advice from more established professional societies such as the American Association of Physicists in Medicine (AAPM) and the American Society for Therapeutic Radiation Oncology (ASTRO) in its efforts to obtain a "Provider Status" for its members.

ASCRO was founded in February 2009, ASCRO obtained its non-profit status in April 2009.

For more information: www.ascro.org


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Subscribe Now